Finn RS, Boer K, Bondarenko I, Patel R, et al. Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18). Breast Cancer Res Treat 2020 Jul 18. pii: 10.1007/s10549-020-05755.
PMID: 32683565